Cite
[Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
MLA
Liu, Lan-Xiang, et al. “[Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].” Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 32, no. 4, Aug. 2024, pp. 1217–23. EBSCOhost, https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.038.
APA
Liu, L.-X., Wang, J., Wang, L., Liu, L., Wang, X., Zhang, H.-B., Tang, X.-Q., & Xiong, Y.-Y. (2024). [Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 32(4), 1217–1223. https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.038
Chicago
Liu, Lan-Xiang, Jing Wang, Li Wang, Lin Liu, Xin Wang, Hong-Bin Zhang, Xiao-Qiong Tang, and Yi-Ying Xiong. 2024. “[Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].” Zhongguo Shi Yan Xue Ye Xue Za Zhi 32 (4): 1217–23. doi:10.19746/j.cnki.issn.1009-2137.2024.04.038.